Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Randomized to Double-blind Treatment	STARTED	Pregabalin 75 mg to 300 mg PO BID	57
Randomized to Double-blind Treatment	STARTED	Placebo 75 mg to 300 mg PO BID	51
Randomized to Double-blind Treatment	COMPLETED	Pregabalin 75 mg to 300 mg PO BID	56
Randomized to Double-blind Treatment	COMPLETED	Placebo 75 mg to 300 mg PO BID	50
Randomized to Double-blind Treatment	NOT COMPLETED	Pregabalin 75 mg to 300 mg PO BID	1
Randomized to Double-blind Treatment	NOT COMPLETED	Placebo 75 mg to 300 mg PO BID	1
Double-blind Treatment Period	STARTED	Pregabalin 75 mg to 300 mg PO BID	56
Double-blind Treatment Period	STARTED	Placebo 75 mg to 300 mg PO BID	50
Double-blind Treatment Period	COMPLETED	Pregabalin 75 mg to 300 mg PO BID	30
Double-blind Treatment Period	COMPLETED	Placebo 75 mg to 300 mg PO BID	19
Double-blind Treatment Period	NOT COMPLETED	Pregabalin 75 mg to 300 mg PO BID	26
Double-blind Treatment Period	NOT COMPLETED	Placebo 75 mg to 300 mg PO BID	31

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00368745/flow